Riskpilot← Back to searchSign inGet full accessBergus Medical AB
ABActiveOrg 5590852736Linnégatan 7General medical practice activities · NACE 8621Est. 20161-4 employees
Revenue 2024
SEK 2,6M
+12% vs 2023
EBITDA margin
23.3%
+177% vs 2023
Equity ratio
3.7%
Financial strength
Net profit 2024
SEK 49K
+390% vs 2023
| Revenue | SEK 2,6M | +12% |
| EBITDA | SEK 609K | +177% |
| Net profit | SEK 49K | +390% |
| Total assets | SEK 4,1M | -10% |
| Equity | SEK 149K | +35% |
| Employees | — | — |
Legal name
Bergus Medical AB
Org number
5590852736
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 november 2016
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva privat finansierad sjukvård samt bedriva därmed förenlig verksamhet.
Address
Linnégatan 7
Email
info@bergus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 667 | 15 876 | 2 237 | 2 341 | 2 612 |
| Staff expenses | — | — | −4 359 | — | — |
| EBITDA | 8 538 | 2 365 | −4 712 | −786 | 609 |
| Depreciation & amort. | −0 | −7 | −11 | −11 | −11 |
| EBIT | 8 538 | 2 358 | −4 723 | −797 | 598 |
| Net financials | −1 | 1 | −8 | 7 | 54 |
| Profit before tax | 4 | 10 | −46 | 10 | 49 |
| Tax | −4 | −10 | 0 | −0 | −0 |
| Net profit | 0 | 0 | −46 | 10 | 49 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 559 | 6 114 | 3 396 | 4 493 | 4 061 |
| Equity | 100 | 100 | 100 | 110 | 149 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 11 459 | 6 004 | 3 296 | 4 383 | 3 912 |
| Total debt | 11 459 | 6 004 | 3 296 | 4 383 | 3 912 |
EBITDA margin
23.3%
This company
15.8%
Market median
+47% vs market
20202024
Equity ratio
3.7%
This company
38.2%
Market median
-90% vs market
20202024
Return on equity
32.9%
This company
18.4%
Market median
+79% vs market
20202024
Net profit margin
1.9%
This company
8.1%
Market median
-77% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
26.26×
This company
0.62×
Market median
-4135% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KJ Chief Executive Officer | Chief Executive Officer | 2021 |
HM | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bergus Holding AB
Bergus Medical AB Board members of Bergus Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Johan Bergling | Chief Executive Officer | 0 companies |
| Hans Mikael Johansson | Audit | 0 companies |
| Sofie Margareta Imhagen | Board of Directors | 0 companies |
| Karl Tomas Bergling | Chairman | 0 companies |